Suppliers and packagers for CLOBEX

CLOBEX

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Galderma Labs Lp	CLOBEX	clobetasol propionate	LOTION;TOPICAL	021535	NDA	Galderma Laboratories, L.P.	0299-3848-02	1 BOTTLE in 1 CARTON (0299-3848-02) / 59 mL in 1 BOTTLE	2003-08-01
Galderma Labs Lp	CLOBEX	clobetasol propionate	LOTION;TOPICAL	021535	NDA	Galderma Laboratories, L.P.	0299-3848-04	1 BOTTLE in 1 CARTON (0299-3848-04) / 118 mL in 1 BOTTLE	2003-08-01
Galderma Labs	CLOBEX	clobetasol propionate	SHAMPOO;TOPICAL	021644	NDA	Galderma Laboratories, L.P.	0299-3847-04	1 BOTTLE in 1 CARTON (0299-3847-04) / 118 mL in 1 BOTTLE	2004-03-01
Galderma Labs	CLOBEX	clobetasol propionate	SHAMPOO;TOPICAL	021644	NDA AUTHORIZED GENERIC	Mayne Pharma Inc.	68308-664-04	1 BOTTLE in 1 CARTON (68308-664-04) / 118 mL in 1 BOTTLE	2023-11-03

Suppliers for the Pharmaceutical Drug: Clobex

Last updated: July 27, 2025

Introduction

Clobex is a topical corticosteroid medication primarily used to treat inflammatory and allergic conditions of the skin, including psoriasis, eczema, and dermatitis. Its active ingredient, clobetasol propionate, is a potent glucocorticoid with anti-inflammatory and immunosuppressive properties. As a widely prescribed treatment, the sourcing and supply chain management for Clobex are critical for ensuring medication availability, regulatory compliance, and cost-effectiveness. This analysis examines the primary suppliers for Clobex, the manufacturing landscape, regulatory considerations, and implications for stakeholders within the pharmaceutical supply chain.

Overview of Clobex Manufacturing and Distribution

Clobex is a branded product produced by Galderma, a prominent pharmaceutical company specializing in dermatological treatments. The drug's formulation typically exists as a topical spray, foam, or lotion. Due to its widespread use, the supply chain involves multiple manufacturing entities, raw material suppliers, distribution channels, and regional distributors.

While some pharmaceutical companies develop Clobex internally, the active pharmaceutical ingredient (API)—clobetasol propionate—may be sourced from specialized chemical manufacturers globally. These API suppliers are critical to the manufacturing process and influence product quality, cost, and regulatory approval.

Key Suppliers of Active Ingredient: Clobetasol Propionate

The core component of Clobex, clobetasol propionate, is produced by a handful of global chemical companies known for synthesizing corticosteroid APIs:

• Piramal Pharma Solutions: A major API manufacturer, Piramal supplies pharmaceutical companies worldwide, including corticosteroid APIs, with a focus on quality and regulatory compliance ([1]).

• Hovione: A global fine chemical manufacturer with expertise in steroid APIs, Hovione supplies clobetasol propionate to various pharmaceutical producers ([2]).

• Novartis (or Novartis API manufacturing units): While Novartis is primarily known for finished formulations, certain divisions produce APIs, including corticosteroids, which may supply formulations like Clobex under licensing agreements.

• Sigma-Aldrich (Merck Group): Offers research-grade corticosteroid intermediates and APIs, which are used by pharma manufacturers in earlier development stages or sometimes in production, depending on regulatory approval ([3]).

• Kindeva Drug Delivery: While primarily a provider of drug delivery systems, Kindeva collaborates with API manufacturers and may be involved in formulation development for corticosteroids, including Clobex formulations ([4]).

The selection of API suppliers depends heavily on quality standards (GMP compliance), regional regulatory approvals, and cost considerations.

Formulation and Finished Product Manufacturers

Galderma manufactures Clobex as a registered dermatological product under strict compliance with regulatory agencies like the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency). The supply chain for finished Clobex involves multiple tiers:

• Contract Manufacturing Organizations (CMOs): Galderma may outsource certain production stages—such as formulation or packaging—to CMOs globally situated in regions with advanced regulatory standards, including Europe, North America, or Asia.

• Regional Distributors and Wholesalers: Once manufactured, Clobex products are distributed through regional distributors to pharmacies, hospitals, and clinics.

Regulatory and Supply Chain Implications

The procurement of Clobex hinges on adherence to regulatory standards for APIs and finished formulations. International supply chains are sensitive to geopolitical, logistical, and compliance issues:

• Regulatory Approvals: API suppliers must hold GMP certification aligned with the target markets (e.g., FDA approval for U.S. supply). Any disruption or non-compliance results in delays or restrictions.

• Quality Assurance: High-quality standards are mandatory due to the potency and topical nature of corticosteroids. Product recalls or regulatory actions can result from supply chain lapses.

• Supply Chain Risks: Global events such as geopolitical tensions, pandemics like COVID-19, or supply chain disruptions can threaten API availability, impacting the ongoing supply of Clobex.

Market Dynamics and Supplier Competition

The market for corticosteroid APIs such as clobetasol propionate is characterized by intense competition among chemical manufacturers. This competition fosters innovation in manufacturing processes, cost reductions, and quality improvements, which benefit pharmaceutical companies procuring the APIs.

Manufacturers looking into alternative sources or regional suppliers often do so to mitigate risks, negotiate better pricing, or comply with regional sourcing requirements. Vertical integration—where pharmaceutical companies develop in-house API manufacturing—is another strategic approach to secure supply.

Conclusion

The supply chain for Clobex is characterized by reliance on a limited pool of high-quality API producers, including Piramal Pharma Solutions, Hovione, and other specialized corticosteroid manufacturers. The drug's manufacturing ecosystem involves complex layers of formulation, quality control, and distribution, all governed by strict regulatory standards. Ensuring a resilient and compliant supply chain is essential for maintaining Clobex availability across global markets.

Key Takeaways

• Primary API suppliers for clobetasol propionate include Piramal Pharma Solutions, Hovione, and major chemical manufacturers, with selection dictated by quality and regulatory compliance.

• Manufacturing partnerships with CMOs and regional distributors play a crucial role in maintaining Clobex supply, emphasizing the importance of rigorous quality assurance and regulatory adherence.

• Supply chain resilience is critical given vulnerabilities such as geopolitical risks, logistical disruptions, and regulatory changes.

• Market competition among API producers fosters innovation, cost competitiveness, and quality improvements, benefiting downstream pharmaceutical manufacturing.

• Regulatory compliance remains paramount, with sourcing strategies often aligning with regional GMP standards to facilitate rapid approval and market access.

FAQs

1. Who are the main API suppliers for Clobex?
   The leading active ingredient suppliers for clobetasol propionate, the active component in Clobex, include Piramal Pharma Solutions, Hovione, and other specialized corticosteroid manufacturers.

2. What considerations influence the choice of API supplier for Clobex?
   Factors include GMP compliance, regulatory approvals, product quality, cost, manufacturing capacity, and regional distribution capabilities.

3. Are there regional differences in Clobex supply chains?
   Yes. Supply chains vary regionally, often driven by regional GMP standards, licensing agreements, and local regulatory requirements to maintain market access.

4. How do supply chain disruptions affect Clobex availability?
   Disruptions in API manufacturing, transportation, or regulatory delays can lead to shortages, impacting patient access and commercial stability.

5. Can Clobex be sourced from generic manufacturers?
   Yes. Several generic pharmaceutical companies produce clobetasol propionate topical formulations, though branded Clobex remains under Galderma's control, with supply tied to their manufacturing and distribution agreements.

References

[1] Piramal Pharma Solutions. "API Manufacturing." Piramal Official Website.

[2] Hovione. "Steroid API Production." Hovione Corporate Information.

[3] Sigma-Aldrich. "Research Chemicals and APIs." Sigma-Aldrich Catalog.

[4] Kindeva Drug Delivery. "Collaborations in Dermatological Formulation Development." Kindeva Official Site.